Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rehabilitation training combined with mouse nerve growth factor in children with provisional intellectual development disorder
ChiCTR2200056223Phase 4Recruiting
- Sponsor
- Jinan Children's Hospital
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of mouse nerve growth factor in disorder of intellectual development (ID) (5 arms), sponsored by Jinan Children's Hospital. Primary endpoint: Gesell developmental diagnostic scale. Started Mar 2022; status: recruiting.
02
Drugs
mouse nerve growth factor
03
Conditions
disorder of intellectual development (ID)
Beyond the preview
Go deeper on ChiCTR2200056223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056223.